Annual report pursuant to Section 13 and 15(d)

COLLABORATION AGREEMENTS - Neurodegenerative Diseases (Details)

v3.22.4
COLLABORATION AGREEMENTS - Neurodegenerative Diseases (Details) - Neurodegen Collaboration
12 Months Ended
Dec. 31, 2022
CAD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
COLLABORATION AGREEMENTS      
Maximum contribution amount per month $ 12,500    
Amount contributed recorded in research and development expenses   $ 0 $ 19,973
BCNI      
COLLABORATION AGREEMENTS      
Amount contributed   $ 0 $ 19,973